{
  "report_rows": [
    {
      "kpi": "Adj. EBITDA (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.027B vs. cons $4.007B",
      "confidence": "HIGH"
    },
    {
      "kpi": "Diluted EPS operating (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$7.59 vs. cons $7.323 (low quality \u2014 DPP-driven)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Same-store equiv. admissions growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred +2.7% vs. cons +2.31%",
      "confidence": "HIGH"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 Adj. EBITDA (FY2026)",
      "prediction": "LOWER",
      "answer": "guide midpoint ~$15.75B vs. cons $15.839B",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 EPS operating (FY2026)",
      "prediction": "LOWER",
      "answer": "guide midpoint ~$29.60 vs. cons $29.998",
      "confidence": "HIGH"
    },
    {
      "kpi": "Exchange headwind tone (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "reaffirm ($1.0B)-($1.2B); risk of 'still dynamic' language",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 qualitative EBITDA trajectory (Q3 2026)",
      "prediction": "LOWER",
      "answer": "implied Q3 EBITDA ~$3.80B vs. cons $3.857B",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 consensus reset to guidance midpoint pulls FY EPS estimates down ~$0.40 over 5 days",
  "day5_confidence": "MEDIUM"
}